课题基金 / 基金详情

Protein Production Core

Protein Production Core
蛋白质生产核心
批准号:
8042887
负责人:
Michael W Cho
金额:
$18.23万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2015-07-31

项目摘要

项目成果

Michael W Cho的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Protein Production Core (Core B) will produce and provide high quality antigens (different variants of gp41-54-GHC) and costimulatory molecules to Projects 1 and 2. The specific aims are: Aim 1. To produce high quality gp41 MPER-based antigens. A major responsibility of this Core is to provide sufficient amount of different variants of gp41-MPER antigens to Project 1 for preparation of multivalent antigens on gold nanoparticles (GNP) and DNA matrix, and for encapsulation in polyanhydride nanoparticles. Recombinant proteins will also be provided to Project 2 for conducting necessary immunoassays to assess B cell responses (e.g. ELISA, ELISPOT, antigen-specific B cell labeling). New recombinant protein constructs will be generated as needed. Antigens will be expressed, purified, and their quality will be carefully monitored prior to usage in Projects 1 and 2. Aim 2. To produce high quality immune effector molecules. Costimulatory molecules CD154 (CD40L) and BLyS will be used to enhance B cell responses by co-presenting them with antigens to B cells either as free proteins or complexed to GNP or DNA matrix. CDI 54 and BLyS will be loaded onto GNP and DNA matrix in Project 1. Alternatively, they can be used directly as soluble proteins (Project 2). Structural and functional integrity of the proteins will be evaluated prior to usage in Projects 1 and 2.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Induction of bnAbs against HIV-1 gp41.
  • 批准号:
    10603692
  • 项目类别:
  • 资助金额:
    $29.73万
  • 财政年份:
    2022
  • 负责人:
    Michael W Cho
  • 依托单位:
Development of a vaccine strategy using antibody-complexed antigens
  • 批准号:
    9161293
  • 项目类别:
  • 资助金额:
    $22.04万
  • 财政年份:
    2016
  • 负责人:
    Michael W Cho
  • 依托单位:
Vaccines Against Antigenically Variable Viruses Symposium
  • 批准号:
    9065323
  • 项目类别:
  • 资助金额:
    $0.75万
  • 财政年份:
    2015
  • 负责人:
    Michael W Cho
  • 依托单位:
Enhancing B cell immunity against HIV-1 using novel vaccine delivery platforms
  • 批准号:
    8310163
  • 项目类别:
  • 资助金额:
    $124.56万
  • 财政年份:
    2010
  • 负责人:
    Michael W Cho
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究